IGC Pharma Inc. has amended its Articles of Incorporation to increase its authorized common stock from 150,000,000 to 600,000,000 shares, following stockholder approval. The total authorized shares now stand at 601,000,000, including 1,000,000 shares of preferred stock.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IGC Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-25-002055), on December 15, 2025, and is solely responsible for the information contained therein.